| IBRX Stock | | | USD 5.04 0.06 1.18% |
Immunitybio financial indicator trend analysis is infinitely more than just investigating Immunitybio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunitybio is a good investment. Please check the relationship between Immunitybio Total Current Liabilities and its Common Stock Total Equity accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunitybio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Immunitybio Stock please use our
How to Invest in Immunitybio guide.
Total Current Liabilities vs Common Stock Total Equity
Total Current Liabilities vs Common Stock Total Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Immunitybio Total Current Liabilities account and
Common Stock Total Equity. At this time, the significance of the direction appears to have strong relationship.
The correlation between Immunitybio's Total Current Liabilities and Common Stock Total Equity is 0.67. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Immunitybio, assuming nothing else is changed. The correlation between historical values of Immunitybio's Total Current Liabilities and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Immunitybio are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Total Current Liabilities i.e., Immunitybio's Total Current Liabilities and Common Stock Total Equity go up and down completely randomly.
Correlation Coefficient | 0.67 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Current Liabilities
Total Current Liabilities is an item on Immunitybio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Immunitybio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Most indicators from Immunitybio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunitybio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunitybio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Immunitybio Stock please use our
How to Invest in Immunitybio guide.At this time, Immunitybio's
Tax Provision is fairly stable compared to the past year.
Sales General And Administrative To Revenue is likely to rise to 802.07 in 2024, whereas
Selling General Administrative is likely to drop slightly above 91.7
M in 2024.
Immunitybio fundamental ratios Correlations
Click cells to compare fundamentals
Immunitybio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunitybio fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to
measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to
predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.